DELIVERY ORDER
Active75N94026F00002
Department of Health and Human Services › National Institutes of Health › NATIONAL INSTITUTES OF HEALTH NICHD
$8.3M
obligated · signed 2 months ago
NICHD: R&D: BESPOKE GENE THERAPY CONSORTIUM (BGTC) - SUPPORT FOR NIH-SPONSORED CLINICAL TRIALS: NON-SEVERABLE
Performance timeline
Start
Sep 28, 2026
End
Sep 27, 2030
with all options
Loading status
Estimated start: Sep 27, 2029
DUKE UNIVERSITY
Contract 75N94026F00002
UEI
TP7EK8DZV6N5
Parent Company
DUKE UNIVERSITY
Capabilities & Certifications
Headquarters Location
Congressional District: 04
Current Obligation
$8,301,883
Base + Exercised Options
$8,301,883
Total Ceiling Value
$8,301,883
Contract Type
COST NO FEE
Multi-Year Contract
NO
NAICS
RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
PSC
HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH
Place of Performance
Congressional District: 04
Awarding Agency
Top-tier agency
National Institutes of Health
Sub-tier agency
NATIONAL INSTITUTES OF HEALTH NICHD
Office
Funding Agency
Top-tier agency
National Institutes of Health
Sub-tier agency
NATIONAL INSTITUTES OF HEALTH NICHD
Office
Contract Vehicle
75N94025D00003
IDCDepartment of Health and Human Services
Award type: SINGLE AWARD
Solicitation procedures, competition exceptions, labor standards and account totals.